HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathleen A Kemmer Selected Research

Therapeutics

12/2018Implementing a comprehensive translational oncology platform: from molecular testing to actionability.
3/2017DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response.
7/2016Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
7/2016Adaptive Randomization of Neratinib in Early Breast Cancer.
2/2016Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kathleen A Kemmer Research Topics

Disease

5Breast Neoplasms (Breast Cancer)
12/2018 - 02/2016
3Neoplasms (Cancer)
07/2016 - 02/2016
2Residual Neoplasm
07/2016 - 02/2016
1Prostatic Neoplasms (Prostate Cancer)
12/2018
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018
1Adenocarcinoma
12/2018
1Triple Negative Breast Neoplasms
07/2016
1Pathologic Complete Response
02/2016

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
03/2017 - 07/2016
2Hormones (Hormone)IBA
07/2016 - 07/2016
1human ERBB2 proteinIBA
07/2016
1veliparibIBA
07/2016
1Trastuzumab (Herceptin)FDA Link
07/2016
1Carboplatin (JM8)FDA LinkGeneric
07/2016
1neratinibIBA
07/2016
1Contrast MediaIBA
02/2016

Therapy/Procedure

5Therapeutics
12/2018 - 02/2016
4Neoadjuvant Therapy
03/2017 - 02/2016
1Drug Therapy (Chemotherapy)
07/2016